Fetal group C trisomy after cytosine arabinoside and thioguanine.
D000014:Abnormalities, Drug-Induced; D000032:Abortion, Therapeutic; D000328:Adult; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D002906:Chromosomes, Human, 6-12 and X; D003561:Cytarabine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009030:Mosaicism; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D013866:Thioguanine / Q000009:adverse effects*; D014314:Trisomy
D003561:Cytarabine; D013866:Thioguanine